Patents
Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226)
07/2006
07/12/2006CN1802350A Azetidinecarboxamide derivatives and their use in the treatment of CB1 receptor mediated disorders
07/12/2006CN1802154A Pyridine N-oxides as antiviral agents
07/12/2006CN1801359A Novel use of dithienylethene compounds
07/12/2006CN1800185A Substituted sulfonamide compounds, process for their use as medicament for the treatment of CNS disorders, obesity and type II diabetes.
07/12/2006CN1800176A Heterocyclic sulfonamide inhibitors of beta amyloid production
07/12/2006CN1263751C Novel compounds
07/12/2006CN1263750C Heterocyclic sulfonamide inhibitors from beta amyloid
07/12/2006CN1263746C Pyridazinone derivatives
07/12/2006CN1263731C Novel immunotherapeutic agents and their use in production of cytokine levels
07/11/2006US7074945 Metal alkoxide taxane derivatives
07/11/2006US7074935 Multistage process with acylation of amine as anesthetics
07/11/2006US7074921 Process for the preparation of 3,7-disubstituted-2,3,4,5-tetrahydro-1H-1,4-benzodiazepine compounds
07/11/2006US7074826 R-NSAID esters and their use
07/11/2006US7074819 Benzopyran or thiobenzopyran derivatives
07/11/2006US7074808 4-(Phenyl-piperidin-4-ylidene-methyl)-benzamide derivatives and their use for the treatment of pain, anxiety or gastrointestional disorders
07/11/2006US7074801 Nitrogen-containing condensed cyclic compound having a pyrazolyl group as a substituent group and pharmaceutical composition thereof
07/11/2006US7074799 To treat one or more conditions responsive to capsaicin receptor modulation, such as pain, itch, urinary incontinence, cough, hiccup, and/or obesity
07/11/2006US7074789 Kinase inhibitors
07/11/2006US7074788 Antidiabetic agents; liver disorders; cardiovascular disorders; dietetics
07/11/2006US7074785 Δ1-pyrrolines used as pesticides
07/11/2006US7074534 Polymeric charge transport compositions and electronic devices made with such compositions
07/11/2006CA2344255C Novel derivatives of heterocycloalkylbenzocyclobutane and heteroarylbenzocyclobutane, process for preparing them and pharmaceutical compositions containing them
07/11/2006CA2285548C Nicotinamide derivatives
07/11/2006CA2274074C Novel compounds with analgesic effect
07/11/2006CA2260999C Heterocyclic compounds, their production and use in tyrosine kinase inhibition
07/11/2006CA2244870C N,n-disubstituted amic acid derivatives
07/11/2006CA2206532C Novel amidinonaphthyl derivative or salt thereof
07/11/2006CA2163244C Quinoline derivatives as leukotriene antagonists
07/11/2006CA2158609C 5 .alpha.-reductase inhibitors
07/11/2006CA2125830C Heteroaryl cinnamic acids as inhibitors of leukotriene biosynthesis
07/11/2006CA2125824C Heteroaryl coumarins as inhibitors of leukotriene biosynthesis
07/06/2006WO2006071958A1 Compounds useful as chemokine receptor antagonists
07/06/2006WO2006070806A1 Novel benzimidazole compound and medicinal composition containing the compound
07/06/2006WO2006070001A1 Substituted indole ligands for the orl-1 receptor
07/06/2006WO2006069946A1 Substituted pyrrolidinones having an antithrombotic effect, the production thereof and their use as medicaments
07/06/2006WO2006069809A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
07/06/2006WO2006069788A1 Organic compounds
07/06/2006WO2006069776A1 5-ht7 receptor antagonists
07/06/2006WO2006069775A1 5-ht7 receptor antagonists
07/06/2006WO2006069767A1 Process for obtaining enantiomers of thienylazolylalcoxyethanamines
07/06/2006WO2006069441A1 Dipyrrole compounds, compositions, and methods for treating cancer or viral diseases
07/06/2006WO2006052893A3 Substituted pyrrolidone compounds as ep4 agonists
07/06/2006WO2006050389A3 Pyridazine compounds, compositions and methods
07/06/2006WO2006047415A3 FACTOR Xa COMPOUNDS
07/06/2006US20060149072 Selective to alpha2B or alpha2C adrenergic receptors, minimal cardivascular or sedatory activity; treating visceral pain, neuropathic pain, corneal pain, glaucoma, elevated intraocular pressure, ischemic neuropathies, neurodegenerative diseases, diarrhea, nasal congestion
07/06/2006US20060149071 Hydrolyzing the ester group of an alkylated 4-amino-4-carboxyamino-piperidine compound and treating the piperidine hydrolysis product with a hydride to produce a 4-hydroxymethyl-piperidine; method requires fewer steps and produces a greater yield of product than known methods; synthetic opioids
07/06/2006US20060149059 Phthalazinone derivatives
07/06/2006US20060148881 Antidepressant cycloalkylamine derivatives of 2,3-dihydro-1,4-Benzodioxan
07/06/2006US20060148879 1-Phenyl-2-oxo-3-sulfonylamino-pyrrolidine derivatives and related compounds as factor xa inhibitors for the treatment of acute vascular diseases
07/06/2006US20060148876 Nr3b1 nuclear receptor binding 3-substituted pyrazoles
07/06/2006US20060148872 2-((2-Thioxo-2,3-dihydro-1H-imidazol-4-yl)methyl)-3,4-dihydronaphthalen-1(2H)-one
07/06/2006US20060148862 Novel compounds that modulate PPARy type receptors and cosmetic/pharmaceutical compositions comprised thereof
07/06/2006US20060148850 4-{'3-(Sulfonylamino) phenyl!'1-(cyclymethyl) piperidin-4-ylidene! methyl}benazmide derivativess as delta opioid receptor ligands for the treatment of pain, anxiety and functional gastrointestinal disorder
07/06/2006US20060148845 In which a pyrrole ring is directly bonded to a 6,5-condensed ring system, such as a benzimidazole, imidazopyridine or imidazopyrimidine system; especially effective against drug resistant bacteria such as MRSA, PRSP, or VRE
07/06/2006US20060148817 Pyrazole compounds
07/06/2006US20060148812 4-cyano-1H-imidazole-2-carboxylic acid {2-cyclohex-1-enyl-4-[1-(2-dimethylamino-acetyl)-piperidin-4-yl]-phenyl}-amide; protein tyrosine kinase inhibitor; autoimmune diseases, antiinflammatory, anticarcinogenic agent
07/06/2006US20060148809 For the therapy of deleterious neurological complaints; anxiolytic agents;cognitive disorders; good affinity as ligands for the alpha 2 and or alpha 3 and or alpha 5 subunit of the human GABAA receptor; 3-(6-Phenylpyridazin-4-yl)thiophene-2-carboxylic Acid Methyl Ester
07/06/2006US20060148792 Substituted 1,4-benzodiazepines and uses thereof
07/06/2006US20060148791 Glutamate receptor antagonists
07/06/2006DE112004001675T5 Dendrimerverbindung und diese verwendendes organisches lumineszierendes Element Dendrimerverbindung and this-use organic luminescent element
07/06/2006DE10248876B4 Verfahren zur Herstellung linearer organischer Oligomere A process for preparing linear organic oligomers
07/06/2006DE102004062544A1 Neue substituierte Pyrrolidinone, deren Herstellung und deren Verewendung als Arzneimittel New substituted pyrrolidinones, their preparation and their Verewendung as medicaments
07/06/2006DE102004061751A1 Cyanoguanidin-substituierte Pyrazoline Cyanoguanidino substituted pyrazolines
07/06/2006DE102004061748A1 Azetidin-substituierte Pyrazoline Azetidine-substituted pyrazolines
07/06/2006DE102004061747A1 Thiophen-substituierte Pyrazoline Thiophene-substituted pyrazolines
07/06/2006CA2592858A1 Substituted indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their preparation and use in medicaments
07/06/2006CA2592131A1 Substituted pyrrolidinones having an antithrombotic effect, the production thereof and their use as medicaments
07/06/2006CA2591201A1 5-ht7 receptor antagonists
07/06/2006CA2590666A1 5-ht7 receptor antagonists
07/06/2006CA2587348A1 Organic compounds
07/05/2006EP1676846A2 Hydantoin derivatives as MMP inhibitors
07/05/2006EP1676844A1 5-HT7 receptor antagonists
07/05/2006EP1676841A1 Substitited indazolyl sulfonamide and 2,3-dihydro-indolyl sulfonamide compounds, their prepartion and use in medicaments
07/05/2006EP1676840A1 5-HT7 Receptor antagonists
07/05/2006EP1676834A1 Fused bicyclic carboxamide derivates for use as CXCR2 inhibitors in the treatment of inflammation
07/05/2006EP1675849A1 Benzimidazolyl derivatives
07/05/2006EP1675836A1 Derivatives of 4-phenylthiazoles and 4-phenylimidazoles and the use thereof as medicaments for treating neurodegenerative diseases, pain and epilepsy
07/05/2006EP1675835A1 Methods of preparation of dehydro-diketopiperazines in liquid phase or of solid supported phase
07/05/2006EP1675832A1 Heterocyclyl compounds
07/05/2006EP1675585A2 Large conductance calcium-activated k channel opener
07/05/2006EP1675584A1 Substituted benzazoles and use thereof as inhibitors of raf kinase
07/05/2006EP1399441B1 N-aroyl cyclic amine derivatives as orexin receptor antagonists
07/05/2006EP1225894B1 Fab i inhibitors
07/05/2006CN1798738A Biaryl substituted pyrazoles as sodium channel blockers
07/05/2006CN1798559A Quinoline-2-one-derivatives for the treatment of airways diseases
07/05/2006CN1262540C Bicycle androgen and progesterone receptor modulator compounds and methods
07/04/2006US7071220 Chymase inhibitor; cardiovascular disorders, circulation diseases; hypotensive agents
07/04/2006US7071216 Anticancer agents
07/04/2006US7071213 Cannabinoid receptor ligands
07/04/2006US7071208 β3 Adrenergic agonists
07/04/2006US7071195 Especially amino- or amido-ethyltetralin derivatives
07/04/2006US7071192 Respiratory system disorders; infections in infants
07/04/2006US7071184 Protease inhibitors
07/04/2006US7071182 Antagonists of melanin concentrating hormone effects on the melanin concentrating hormone receptor
07/04/2006CA2332066C Tetrazole compounds as thyroid receptor ligands
06/2006
06/29/2006WO2006069275A1 Tricyclic delta-opioid modulators
06/29/2006WO2006069196A1 3-cycloalkylcarbonyl indoles as cannabinoid receptor ligands
06/29/2006WO2006067466A2 Pyrazines and pyridines and derivatives thereof as therapeutic compounds
06/29/2006WO2006067428A2 1, 2-diphenyl-imidazole derivatives and their use as cb1 receptor ligands
06/29/2006WO2006067414A2 Glycine transport inhibitors